| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |